Merck (MRK) Property, Plant & Equipment (Net) (2009 - 2026)

Merck (MRK) Property, Plant & Equipment (Net) (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn 12.59 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn 26.54 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn 23.27 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn 5.69 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn 25.43 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn 8.22 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn 5.64 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn 19.40 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn 7.66 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 25.43 Bn
Mar 31, 2026 25.43 Bn
Dec 31, 2025 25.32 Bn
Dec 31, 2025 25.32 Bn
Sep 30, 2025 25.64 Bn
Sep 30, 2025 25.64 Bn
Jun 30, 2025 25.24 Bn
Jun 30, 2025 25.24 Bn
Mar 31, 2025 759.00 Mn
Mar 31, 2025 759.00 Mn
Dec 31, 2024 23.78 Bn
Dec 31, 2024 23.78 Bn
Sep 30, 2024 23.45 Bn
Sep 30, 2024 23.45 Bn
Jun 30, 2024 23.22 Bn
Jun 30, 2024 23.22 Bn
Mar 31, 2024 23.05 Bn
Mar 31, 2024 23.05 Bn
Dec 31, 2023 23.05 Bn
Dec 31, 2023 23.05 Bn